(Q53341914)

13 May 2018

title

The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. (English)

1 reference

13 May 2018

1 reference

1 reference

1 reference

Caprini JA

1

1 reference

13 May 2018

Arcelus JI

2

1 reference

13 May 2018

Motykie G

3

1 reference

13 May 2018

Kudrna JC

4

1 reference

13 May 2018

Mokhtee D

5

1 reference

13 May 2018

Reyna JJ

6

1 reference

13 May 2018

publication date

1 November 1999

1 reference

13 May 2018

Journal of Vascular Surgery

published in

1 reference

13 May 2018

volume

30

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

813-820

1 reference

13 May 2018

Failure of low-dose heparin to prevent deep-vein thrombosis after hip-replacement arthroplasty

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Thrombosis following hip arthroplasty. A study using phlebography and 125I-fibrinogen test

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

The natural history and aetiology of deep vein thrombosis after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Postoperative pulmonary embolism after hospital discharge. An underestimated risk

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Prevention of venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

The operative treatment of peroneal nerve palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Prevention of fatal pulmonary embolism with warfarin after total hip replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Limitations of compression ultrasound for the detection of symptomless postoperative deep vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Screening for deep-venous thrombosis after hip and knee replacement without prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Postoperative mortality after total hip arthroplasty. An analysis of deaths after two thousand seven hundred and thirty-six procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

RD heparin compared with warfarin for prevention of venous thromboembolic disease following total hip or knee arthroplasty. RD Heparin Arthroplasty Group

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

The international normalized ratio. A guide to understanding and correcting its problems

1 reference

https://api.crossref.org/works/10.1016%2FS0741-5214%2899%2970005-4

7 January 2021

10.1016/S0741-5214(99)70005-4

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018